These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2311478)

  • 1. Pharmacokinetics of cefotaxime in preterm infants.
    Gouyon JB; Pechinot A; Safran C; Chretien P; Sandre D; Kazmierczak A
    Dev Pharmacol Ther; 1990; 14(1):29-34. PubMed ID: 2311478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefotaxime and desacetylcefotaxime pharmacokinetics in very low birth weight neonates.
    Kearns GL; Jacobs RF; Thomas BR; Darville TL; Trang JM
    J Pediatr; 1989 Mar; 114(3):461-7. PubMed ID: 2921690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of cefotaxime and desacetylcefotaxime in the newborn.
    Aujard Y; Brion F; Jacqz-Aigrain E; Kasse MC; Chretien P; Criqui C; Mathieu H
    Diagn Microbiol Infect Dis; 1989; 12(1):87-91. PubMed ID: 2653716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative pharmacokinetics of cefotaxime in serum and bile during continuous and intermittent infusion in liver transplant patients.
    Buijk SE; Gyssens IC; Mouton JW; Metselaar HJ; Groenland TH; Verbrugh HA; Bruining HA
    J Antimicrob Chemother; 2004 Jul; 54(1):199-205. PubMed ID: 15175266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefotaxime and desacetylcefotaxime pharmacokinetics in infants and children with meningitis.
    Trang JM; Jacobs RF; Kearns GL; Brown AL; Wells TG; Underwood FL; Kluza RB
    Antimicrob Agents Chemother; 1985 Dec; 28(6):791-5. PubMed ID: 4083862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of cefotaxime and its active metabolite in children with renal dysfunction.
    Paap CM; Nahata MC; Mentser MA; Mahan JD; Puri SK; Hubbard JW
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1879-83. PubMed ID: 1952862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of cefotaxime and desacetylcefotaxime in infants during extracorporeal membrane oxygenation.
    Ahsman MJ; Wildschut ED; Tibboel D; Mathot RA
    Antimicrob Agents Chemother; 2010 May; 54(5):1734-41. PubMed ID: 20176908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of pharmacokinetics and serum bactericidal activity of ceftizoxime and cefotaxime.
    Vallée F; LeBel M
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2057-64. PubMed ID: 1759827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NONMEM analysis in determining the tri-exponential disposition of cefotaxime: a method of evaluating serum and urinary phase I data.
    Weber W; Harnisch L; Zimmer M; Rokitta C; Mendes P
    Int J Clin Pharmacol Ther; 1995 Oct; 33(10):560-4. PubMed ID: 8574507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the biliary clearances of cefotaxime and desacetylcefotaxime by an original procedure in cholecystectomised patients.
    Jehl F; Peter JD; Picard A; Dupeyron JP; Marescaux J; Sibilly A; Monteil H
    Infection; 1987; 15(6):450-4. PubMed ID: 3436677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic modelling of cefotaxime and desacetylcefotaxime--a population study in 25 elderly patients.
    Urien S; Laurent N; Barre J; Druguet M; Bouvier D'yvoire M; Maire P
    Eur J Clin Pharmacol; 2004 Mar; 60(1):11-6. PubMed ID: 14767629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cefotaxime and desacetylcefotaxime in cerebrospinal fluid of newborn and premature infants].
    von Loewenich V; Miething R; Uihlein M; Knothe H; Greipel-Zamorski M
    Padiatr Padol; 1983; 18(4):361-6. PubMed ID: 6316232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of fever on cefotaxime pharmacokinetics].
    Demotes-Mainard F; Albin H; Ragnaud JM; Gin H; Vincon G; Aubertin J
    Pathol Biol (Paris); 1988 Feb; 36(2):155-8. PubMed ID: 3279384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Basic and clinical studies of cefotiam in neonates and premature infants].
    Iwata S; Sato Y; Kusumoto Y; Shiro H; Akita H; Nanri S; Oikawa T; Osano M; Sunakawa K
    Jpn J Antibiot; 1986 Sep; 39(9):2407-20. PubMed ID: 3540358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the bactericidal activity of cefotaxime and desacetylcefotaxime alone and in combination against Bacteroides fragilis group organisms.
    Aldridge KE; Weeks LS; Stratton CW; Sanders CV
    Diagn Microbiol Infect Dis; 1989; 12(2):165-70. PubMed ID: 2752714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of cefotaxime and desacetylcefotaxime in patients with liver disease.
    Ko RJ; Sattler FR; Nichols S; Akriviadis E; Runyon B; Appleman M; Cohen JL; Koda RT
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1376-80. PubMed ID: 1929296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of cefotaxime in the postpartum patient.
    Gonik B; Cotton DB; Feldman S; Cleary TG; Pickering LK
    Am J Perinatol; 1985 Apr; 2(2):114-7. PubMed ID: 4096751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefotaxime and desacetylcefotaxime in neonates and children: a review of microbiologic, pharmacokinetic, and clinical experience.
    Jacobs RF; Kearns GL
    Diagn Microbiol Infect Dis; 1989; 12(1):93-9. PubMed ID: 2653717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of cefotaxime and desacetylcefotaxime in the young.
    Kearns GL; Young RA
    Diagn Microbiol Infect Dis; 1995; 22(1-2):97-104. PubMed ID: 7587057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro synergy between cefotaxime and its main metabolite, desacetylcefotaxime].
    Kobayashi S; Arai S; Hayashi S; Sakaguchi T; Kawana R
    Jpn J Antibiot; 1988 May; 41(5):594-601. PubMed ID: 3216482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.